Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

11.98
Delayed Data
As of Jul 21
 -0.33 / -2.68%
Today’s Change
8.70
Today|||52-Week Range
19.96
+30.22%
Year-to-Date
Abbott Labs (ABT) Beats on Q2 Earnings and Sales, View Up
Jul 20 / Zacks.com - Paid Partner Content
Medtronic InterStim System Shows Five-Year Positive Results
Jul 18 / Zacks.com - Paid Partner Content
Quest Diagnostics Closes Deal to Acquire 2 Labs in Texas
Jul 20 / Zacks.com - Paid Partner Content
Company News for July 17, 2017
Jul 17 / Zacks.com - Paid Partner Content
Align Technology Hits a 52-Week High on Solid Prospects
Jul 18 / Zacks.com - Paid Partner Content
Hill-Rom (HRC) at 52-Week High: What's Driving the Stock?
Jul 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close12.31
Today’s open12.27
Day’s range11.79 - 12.51
Volume607,695
Average volume (3 months)638,153
Market cap$864.1M
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-87.01%
Earnings growth (this year)-211.05%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)-26.76%
P/E ratioNM
Price/Sales2.82
Price/Book3.20

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...0.000.00%
HRTXHeron Therapeutics I...-1.05-6.00%
PTCTPTC Therapeutics Inc+1.10+5.41%
AMPHAmphastar Pharmaceut...+0.53+2.96%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$242.3M
Annual profit (last year)$7.6M
Net profit margin3.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Saeed Motahari
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts